Deferasirox (Exjade®) Significantly Improves Cardiac T2* in Heavily Iron-Overloaded Patients With Β-Thalassemia Major
Annals of Hematology - Germany
doi 10.1007/s00277-009-0838-z
Full Text
Open PDFAbstract
Available in full text
Date
October 2, 2009
Authors
Publisher
Springer Science and Business Media LLC